Literature DB >> 20306470

Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity.

Oryan Makler1, Kfir Oved, Nir Netzer, Dana Wolf, Yoram Reiter.   

Abstract

There are no direct means to study class I MHC presentation in human normal or diseased cells. Using CMV-infected human cells and applying novel mAb that mimic T-cell receptor specificity directed toward the immunogenic epitope of the viral pp65 protein presented on HLA-A2 molecules, we directly imaged the dynamics of Ag presentation in infected cells. We demonstrate that following infection large intracellular pools of HLA-A2/pp65 complexes are localized to the Golgi. These HLA-A2/pp65 pools account for the majority of total HLA-A2 molecules in infected cells. Interestingly, these large pools are sequestered inside infected cells and only a small portion of them are exported to the cell surface. Virus-induced class I MHC down-regulation did not affect the intracellular pool of HLA-A2/pp65 complexes. Our data also suggest that proteasome function influences the release of class I complexes to the membrane. We present herein a new and direct molecular tool to study the dynamics of viral Ag presentation that may further elucidate the balance between immune response versus viral escape.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20306470     DOI: 10.1002/eji.200939875

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.

Authors:  Brian P Dolan; Aditi A Sharma; James S Gibbs; Tshaka J Cunningham; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

Review 2.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

3.  Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65.

Authors:  Nadine Frankenberg; Peter Lischka; Sandra Pepperl-Klindworth; Thomas Stamminger; Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2012-09-11       Impact factor: 3.402

4.  Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters.

Authors:  Xiuju Lu; James S Gibbs; Heather D Hickman; Alexandre David; Brian P Dolan; Yetao Jin; David M Kranz; Jack R Bennink; Jonathan W Yewdell; Rajat Varma
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

Review 5.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

Review 6.  TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.

Authors:  Jon A Weidanz; Oriana Hawkins; Bhavna Verma; William H Hildebrand
Journal:  Int Rev Immunol       Date:  2011 Oct-Dec       Impact factor: 5.311

7.  Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display.

Authors:  Ellen K Wagner; Ahlam N Qerqez; Christopher A Stevens; Annalee W Nguyen; George Delidakis; Jennifer A Maynard
Journal:  J Biol Chem       Date:  2019-02-22       Impact factor: 5.157

8.  Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.

Authors:  Saghar Kaabinejadian; Curtis P McMurtrey; Sojung Kim; Rinki Jain; Wilfried Bardet; Fredda B Schafer; Jason L Davenport; Aaron D Martin; Michael S Diamond; Jon A Weidanz; Ted H Hansen; William H Hildebrand
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422

Review 9.  Opportunities and challenges for TCR mimic antibodies in cancer therapy.

Authors:  Aaron Y Chang; Ron S Gejman; Elliott J Brea; Claire Y Oh; Melissa D Mathias; Dmitry Pankov; Emily Casey; Tao Dao; David A Scheinberg
Journal:  Expert Opin Biol Ther       Date:  2016-04-27       Impact factor: 4.388

10.  A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.

Authors:  Sojung Kim; Amelia K Pinto; Nancy B Myers; Oriana Hawkins; Krysten Doll; Saghar Kaabinejadian; Jason Netland; Michael J Bevan; Jon A Weidanz; William H Hildebrand; Michael S Diamond; Ted H Hansen
Journal:  Eur J Immunol       Date:  2014-05-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.